Metabotropic Glutamate Receptor 2/3 Activation Improves Motor Performance and Reduces Pathology in Heterozygous zQ175 Huntington Disease Mice
Si Han Li(University of Ottawa), Stephen S. G. Ferguson(University of Ottawa)
Cited by 18
Related Papers
Regulation of GPCR activity, trafficking and localization by GPCR‐interacting proteins
|British Journal of Pharmacology|2011|353
Inhibition of Metabotropic Glutamate Receptor Signaling by the Huntingtin-binding Protein Optineurin
|Journal of Biological Chemistry|2005|141
Modulation of mTOR and CREB pathways following mGluR5 blockade contribute to improved Huntington’s pathology in zQ175 mice
|Molecular Brain|2019|67